More on JNJ

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+13.4% Growth)
- Ratings (4.2 Score)
- Holders
- Dividends (3% Yield)
- Event Driven Deals
- FDA

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (4/13/16 *Est.)
- Ex-Dividend (2/19/2016)
- Spin-Off (12/31/15 *Est)
- PDUFA (3/9/2016)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

JNJ Cash Flow Statement

Click line-items for a historical chart and %
CASH FLOW FROM OPERATING ACTIVITIES
Net earnings
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property and intangibles 2.71B
Stock based compensation 677M
Deferred tax provision 233M
Accounts receivable allowances 2M
Changes in assets and liabilities, net of effects from acquisitions:
Increase in accounts receivable -910M
Increase in inventories -719M
Decrease in accounts payable and accrued liabilities -1.56B
Increase in other current and non-current assets 986M
Increase in other current and non-current liabilities 1.49B
NET CASH FLOWS FROM OPERATING ACTIVITIES 14.2B
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property, plant and equipment -2.1B
Proceeds from the disposal of assets 1.62B
Acquisitions, net of cash acquired -233M
Purchases of investments -28.77B
Sales of investments 23.17B
Other -35M
NET CASH USED BY INVESTING ACTIVITIES -6.34B
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends to shareholders -6.1B
Repurchase of common stock -3.39B
Proceeds from short-term debt 2.11B
Retirement of short-term debt -930M
Proceeds from long-term debt 3M
Retirement of long-term debt -27M
Proceeds from the exercise of stock options/ excess tax benefits
NET CASH USED BY FINANCING ACTIVITIES -7.56B
Effect of exchange rate changes on cash and cash equivalents -1.18B
Decrease in cash and cash equivalents -884M
Cash and Cash equivalents, beginning of period 14.52B
CASH AND CASH EQUIVALENTS, END OF PERIOD 13.64B
Acquisitions
Fair value of assets acquired 477M
Fair value of liabilities assumed and non-controlling interests -244M
Net cash paid for acquisitions 233M